Stephen Schloss, MD
Urology · Concord, MANPI 1588662407
Payments from drug & device makers
Across 51 payments — averaging $120.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gyrus ACMI, Inc.$3K
- Teleflex LLC$1K
- Boston Scientific$439
- Procept Biorobotics Corporation$335
- AbbVie$289
- Urogen Pharma, Inc.$287
- plus $686 from 13 others
What the payments were for
- Consulting fees$2,60042%
- Speaking & faculty fees$5509%
- Travel & lodging$98616%
- Food & beverage$2,01633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gyrus ACMI, Inc. | 2 | $3,050 |
| Teleflex LLC | 9 | $1,065 |
| Boston Scientific | 6 | $439 |
| Procept Biorobotics Corporation | 2 | $335 |
| AbbVie(2 entities) | 5 | $289 |
| Urogen Pharma, Inc. | 5 | $287 |
| Angiodynamics, Inc. | 1 | $166 |
| Astellas Pharma US Inc | 4 | $119 |
| Comsort, Inc | 1 | $100 |
| Progenics Pharmaceuticals, Inc. | 3 | $75 |
| Myriad Genetic Laboratories, Inc. | 3 | $58 |
| Coloplast | 3 | $45 |
| Laborie Medical Technologies Corp. | 1 | $30 |
| Agiliti Surgical, Inc. | 1 | $20 |
| Blue Earth Diagnostics | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Tolmar, Inc. | 1 | $15 |
| Photocure Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Soltive$2,500
- UroLift System$535
- GENERAL KIDNEY STONE DISEASE$367
- UroLift$313
- BOTOX$223
- AQUABEAM SYSTEM$169
- AquaBeam Robotic System$166
- Nanoknife$166
- ZUSDURI$121
- KEYTRUDA$100
How this compares
$6,152 in reported general payments places this provider in the 70th percentile of 327 urology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 19 | $14,224 |
| Tamsulosin Hcl | 448 | $8,711 |
| Finasteride | 281 | $5,114 |
| Testosterone | 21 | $2,578 |
| Oxybutynin Chloride ErOxybutynin Chloride | 70 | $2,169 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 153 | $933 |
| Dutasteride | 11 | $610 |
| Terazosin Hcl | 16 | $492 |
| Ciprofloxacin Hcl | 58 | $438 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $351 |
| Doxazosin Mesylate | 13 | $317 |
| Doxycycline Monohydrate | 21 | $309 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $255 |
| Allopurinol | 17 | $224 |
| Levofloxacin | 53 | $212 |
Paid to pharmacies, not to this prescriber.
Other urology in Concord
- Christopher CutieBoston$3.5M
- Henry MitchesonWatertown$1.6M
- Brian EisnerBoston$1.4M
- Mark PrestonBoston$1.2M
- David StaskinBrighton$807K
- Abraham MorgentalerChestnut Hill$522K
- Alejandro SanchezBoston$349K
- Liam HurleyNorth Andover$319K
- Adam KibelBoston$316K
- Tony LuongoBoston$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.